Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma

Abstract

The novel CR risk signature greatly contributed to the clinical assessment of HCC. Cuproptosis regulatory gene DLAT possessed cancer-promoting capacities and was expected to be a promising therapeutic target for HCC.